Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10588901 Combination therapy

Patent 10588901 was granted and assigned to Aerie Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12018012 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11891376 Aryl cyclopropyl-amino-isoquinolinyl amide compounds
0
Edits on 11 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 11 Dec, 2023
Edits made to:
Article (+458 characters)
Article

Patent abstract

Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.

Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11707460 Ophthalmic compositions
0
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11020385 Combination therapy
0
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 8 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11618748 Dual mechanism inhibitors for the treatment of disease
0
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11590123 Ophthalmic compositions
0
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 29 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 1 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11590123 Ophthalmic compositions
0
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 11020385 Combination therapy
0
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11028081 Dual mechanism inhibitors for the treatment of disease
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11020385 Combination therapy
Edits on 2 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Feb, 2022
Edits made to:
Infobox (+10 properties)
‌

 US Patent 10588901 Combination therapy

Infobox
Is a
Patent
Patent
Current assignee
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10588901
Date of patent
March 17, 2020
Patent application number
15970635
Date Filed
May 3, 2018
Patent citations
‌
US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
‌
US Patent 10174017 Dual mechanism inhibitors for the treatment of disease
Patent primary examiner
‌
James D. Anderson

Find more entities like US Patent 10588901 Combination therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.